miR-101-5p modulation of CD47 in diffuse large B-cell lymphoma: Implications for anti-CD47 immunotherapy and prognostication

Br J Haematol. 2024 Feb;204(2):730-734. doi: 10.1111/bjh.19264. Epub 2023 Dec 12.

Authors

Muhammad Sufyan Bin Masroni¹, Sai Mun Leong^{1

2}, He Cheng³, Geng Sheng Lim¹, Nicole Zi Yi Heng¹, Chao Teng Law¹, Shirin Ashraff⁴, Soo Yong Tan^{1

2

4}, Susan Swee Shan Hue^{1

2

4}

Affiliations

¹ Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
² NUS Centre for Cancer Research (N2CR), MD6, Centre for Translational Medicine, National University of Singapore, Singapore, Singapore.
³ MiRXES Pte Ltd., Singapore, Singapore.
⁴ Department of Pathology, National University Hospital, Singapore, Singapore.

PMID: 38087456
DOI: 10.1111/bjh.19264

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

CD47 Antigen
Humans
Immunotherapy
Lymphoma, Large B-Cell, Diffuse*
MicroRNAs*

Substances

CD47 Antigen
MicroRNAs
CD47 protein, human
MIRN101 microRNA, human

Grants and funding